Connection

Robert Grubb to Middle Aged

Back to Details
This is a "connection" page, showing publications Robert Grubb has written about Middle Aged.
Robert Grubb
Connection Strength
0.671
Middle Aged
  1. The REDUCE Follow-Up Study: low rate of new prostate cancer diagnoses observed during a 2-year, observational, followup study of men who participated in the REDUCE trial. J Urol. 2013 Mar; 189(3):871-7.
    View in: PubMed
    Score: 0.031
  2. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int. 2008 Dec; 102(11):1524-30.
    View in: PubMed
    Score: 0.024
  3. High-grade prostate cancer in the Prostate Cancer Prevention Trial: fact or artifact? J Natl Cancer Inst. 2007 Sep 19; 99(18):1355-6.
    View in: PubMed
    Score: 0.022
  4. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol. 2007 Jun; 177(6):2074-9; discussion 2079-80.
    View in: PubMed
    Score: 0.021
  5. Can preoperative PSA doubling time and PSA velocity predict outcomes following radical prostatectomy? Nat Clin Pract Urol. 2006 Jun; 3(6):306-7.
    View in: PubMed
    Score: 0.020
  6. Use of titanium staples during upper tract laparoscopic reconstructive surgery: initial experience. J Urol. 2002 Oct; 168(4 Pt 1):1366-9.
    View in: PubMed
    Score: 0.015
  7. One-year urinary and sexual outcome trajectories among prostate cancer patients treated by radical prostatectomy: a prospective study. BMC Urol. 2021 May 17; 21(1):81.
    View in: PubMed
    Score: 0.014
  8. Recurrent Hemispheric Stroke Syndromes in Symptomatic Atherosclerotic Internal Carotid Artery Occlusions: The Carotid Occlusion Surgery Study Randomized Trial. Neurosurgery. 2020 07 01; 87(1):137-141.
    View in: PubMed
    Score: 0.013
  9. Risk of Prostate Cancer-related Death Following a Low PSA Level in the PLCO Trial. Cancer Prev Res (Phila). 2020 04; 13(4):367-376.
    View in: PubMed
    Score: 0.013
  10. The association of marital status and mortality among men with early-stage prostate cancer treated with radical prostatectomy: insight into post-prostatectomy survival strategies. Cancer Causes Control. 2019 Aug; 30(8):871-876.
    View in: PubMed
    Score: 0.012
  11. Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer. Cancer Med. 2019 07; 8(8):3698-3709.
    View in: PubMed
    Score: 0.012
  12. Levels and patterns of self-reported and objectively-measured free-living physical activity among prostate cancer survivors: A prospective cohort study. Cancer. 2019 03 01; 125(5):798-806.
    View in: PubMed
    Score: 0.012
  13. Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial. BJU Int. 2019 05; 123(5):854-860.
    View in: PubMed
    Score: 0.012
  14. Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy. Eur Urol Oncol. 2018 06; 1(2):143-148.
    View in: PubMed
    Score: 0.011
  15. Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram. Urology. 2018 03; 113:119-128.
    View in: PubMed
    Score: 0.011
  16. Intravesical rAd-IFNa/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol. 2017 Oct 20; 35(30):3410-3416.
    View in: PubMed
    Score: 0.011
  17. Caution with Use of the EPIC-50 Urinary Bother Scale: How Voiding Dysfunction Modifies its Performance. J Urol. 2017 12; 198(6):1397-1403.
    View in: PubMed
    Score: 0.011
  18. Trichomonas vaginalis infection and risk of prostate cancer: associations by disease aggressiveness and race/ethnicity in the PLCO Trial. Cancer Causes Control. 2017 Aug; 28(8):889-898.
    View in: PubMed
    Score: 0.011
  19. Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials. 2017 04 18; 18(1):181.
    View in: PubMed
    Score: 0.011
  20. Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer. 2017 Feb 15; 123(4):592-599.
    View in: PubMed
    Score: 0.010
  21. Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary? Urology. 2017 04; 102:190-197.
    View in: PubMed
    Score: 0.010
  22. Radiation Therapy for Residual or Recurrent Atypical Meningioma: The Effects of Modality, Timing, and Tumor Pathology on Long-Term Outcomes. Neurosurgery. 2016 Jul; 79(1):23-32.
    View in: PubMed
    Score: 0.010
  23. Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States. J Urol. 2016 Oct; 196(4):1096-104.
    View in: PubMed
    Score: 0.010
  24. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. J Natl Cancer Inst. 2015 Dec; 107(12):djv279.
    View in: PubMed
    Score: 0.009
  25. Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation. Urol Oncol. 2015 Jul; 33(7):330.e9-17.
    View in: PubMed
    Score: 0.009
  26. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. BJU Int. 2016 Jan; 117(1):145-54.
    View in: PubMed
    Score: 0.009
  27. Physical activity and benign prostatic hyperplasia-related outcomes and nocturia. Med Sci Sports Exerc. 2015 Mar; 47(3):581-92.
    View in: PubMed
    Score: 0.009
  28. Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery. 2014 Oct; 75(4):347-54; discussion 354-5; quiz 355.
    View in: PubMed
    Score: 0.009
  29. Management of atypical cranial meningiomas, part 2: predictors of progression and the role of adjuvant radiation after subtotal resection. Neurosurgery. 2014 Oct; 75(4):356-63; discussion 363.
    View in: PubMed
    Score: 0.009
  30. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2374-82.
    View in: PubMed
    Score: 0.009
  31. Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC). BJU Int. 2014 Jul; 114(1):98-103.
    View in: PubMed
    Score: 0.009
  32. Evaluation of 3 T pelvic MRI imaging in prostate cancer patients receiving post-prostatectomy IMRT. World J Urol. 2015 Jan; 33(1):69-75.
    View in: PubMed
    Score: 0.008
  33. Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial: main results. Neurology. 2014 Mar 04; 82(9):744-51.
    View in: PubMed
    Score: 0.008
  34. Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro Oncol. 2014 Jan; 16(1):123-30.
    View in: PubMed
    Score: 0.008
  35. The safety of aeroplane travel in patients with symptomatic carotid occlusion. J Neurol Neurosurg Psychiatry. 2014 Apr; 85(4):435-7.
    View in: PubMed
    Score: 0.008
  36. Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer screening trial participants. Cancer Epidemiol Biomarkers Prev. 2013 Dec; 22(12):2241-9.
    View in: PubMed
    Score: 0.008
  37. Biopsy of the superficial cortex: predictors of effectiveness and outcomes. Neurosurgery. 2013 Aug; 73(2):224-31; discussion 231-2; quiz 232.
    View in: PubMed
    Score: 0.008
  38. Reproductive factors and kidney cancer risk in 2 US cohort studies, 1993-2010. Am J Epidemiol. 2013 Jun 15; 177(12):1368-77.
    View in: PubMed
    Score: 0.008
  39. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer. 2013 Jun 15; 119(12):2223-9.
    View in: PubMed
    Score: 0.008
  40. Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res. 2013 Apr 01; 73(7):2211-20.
    View in: PubMed
    Score: 0.008
  41. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans? Urol Oncol. 2014 Jan; 32(1):34.e9-18.
    View in: PubMed
    Score: 0.008
  42. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. Eur Urol. 2013 Sep; 64(3):372-8.
    View in: PubMed
    Score: 0.008
  43. Adenocarcinoma in an ileal conduit. J Urol. 2013 Feb; 189(2):697-8.
    View in: PubMed
    Score: 0.008
  44. Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiol. 2012 Dec; 36(6):e401-6.
    View in: PubMed
    Score: 0.008
  45. Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials. Cancer. 2013 Feb 01; 119(3):593-601.
    View in: PubMed
    Score: 0.008
  46. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012 Jan 18; 104(2):125-32.
    View in: PubMed
    Score: 0.007
  47. Population based analysis of the increasing incidence of kidney cancer in the United States: evaluation of age specific trends from 1975 to 2006. J Urol. 2012 Jan; 187(1):32-8.
    View in: PubMed
    Score: 0.007
  48. Intestinal adenocarcinoma arising in urinary conduits. Oncol Rep. 2012 Feb; 27(2):371-5.
    View in: PubMed
    Score: 0.007
  49. Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial cancer. Urol Oncol. 2013 Aug; 31(6):894-8.
    View in: PubMed
    Score: 0.007
  50. Positive margin during partial nephrectomy: does cancer remain in the renal remnant? Urology. 2011 Jun; 77(6):1400-3.
    View in: PubMed
    Score: 0.007
  51. Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol. 2011 Feb 01; 29(4):355-61.
    View in: PubMed
    Score: 0.007
  52. Splenic injury during percutaneous nephrolithotomy: a case report with novel management technique. J Endourol. 2010 Apr; 24(4):541-5.
    View in: PubMed
    Score: 0.006
  53. Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010 Mar; 183(3):909-14.
    View in: PubMed
    Score: 0.006
  54. Effect of reclassification on the incidence of benign and malignant renal tumors. J Urol. 2010 Feb; 183(2):455-8.
    View in: PubMed
    Score: 0.006
  55. Preoperative sensorimotor mapping in brain tumor patients using spontaneous fluctuations in neuronal activity imaged with functional magnetic resonance imaging: initial experience. Neurosurgery. 2009 Dec; 65(6 Suppl):226-36.
    View in: PubMed
    Score: 0.006
  56. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection. Urol Oncol. 2011 Nov-Dec; 29(6):738-44.
    View in: PubMed
    Score: 0.006
  57. Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol. 2009 Sep 10; 27(26):4314-20.
    View in: PubMed
    Score: 0.006
  58. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009 Mar 26; 360(13):1310-9.
    View in: PubMed
    Score: 0.006
  59. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):748-51.
    View in: PubMed
    Score: 0.006
  60. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control. 2008 Dec; 19(10):1267-76.
    View in: PubMed
    Score: 0.006
  61. Combined surgical resection and stereotactic radiosurgery for treatment of cerebral metastases. Surg Neurol. 2009 Mar; 71(3):280-8, disucssion 288-9.
    View in: PubMed
    Score: 0.006
  62. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. BJU Int. 2008 Jan; 101(2):181-5.
    View in: PubMed
    Score: 0.005
  63. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int. 2007 May; 99(5):1041-6.
    View in: PubMed
    Score: 0.005
  64. Prostate-specific antigen velocity and prostate cancer gleason grade and stage. Cancer. 2007 Apr 15; 109(8):1689-95.
    View in: PubMed
    Score: 0.005
  65. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial. BJU Int. 2007 Apr; 99(4):775-9.
    View in: PubMed
    Score: 0.005
  66. Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial. Urology. 2006 Aug; 68(2):352-6.
    View in: PubMed
    Score: 0.005
  67. Results of compliance with prostate cancer screening guidelines. J Urol. 2005 Aug; 174(2):668-72; discussion 672.
    View in: PubMed
    Score: 0.005
  68. Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J Neurosurg. 2005 Jul; 103(1):25-30.
    View in: PubMed
    Score: 0.005
  69. Evaluation and management of renal tumors in the Birt-Hogg-Dub? syndrome. J Urol. 2005 May; 173(5):1482-6.
    View in: PubMed
    Score: 0.005
  70. Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml. J Urol. 2005 Apr; 173(4):1116-20.
    View in: PubMed
    Score: 0.005
  71. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst. 2005 Mar 16; 97(6):433-8.
    View in: PubMed
    Score: 0.005
  72. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 2004 Jul; 172(1):63-5.
    View in: PubMed
    Score: 0.004
  73. Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction. J Urol. 2003 Jun; 169(6):2037-40.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.